ENDRA LIFE SCIENCES INC. (NDRA) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
9/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseNDRA / S&P 14.62% / 15.20% |
LoseNDRA / S&P NDRA unavailable / 15.00% |
LoseNDRA / S&P -152.77% / 50.40% |
| 2026-Q11/3 |
WinNDRA / S&P 2.65% / -4.33% |
LoseNDRA / S&P NDRA unavailable / 11.30% |
LoseNDRA / S&P NDRA unavailable / 27.70% |
| 2025-Q40/3 |
LoseNDRA / S&P -15.80% / 2.65% |
LoseNDRA / S&P NDRA unavailable / 9.00% |
LoseNDRA / S&P NDRA unavailable / 13.40% |
| 2025-Q31/3 |
WinNDRA / S&P 53.28% / 8.12% |
LoseNDRA / S&P NDRA unavailable / 4.61% |
LoseNDRA / S&P NDRA unavailable / 13.45% |
| 2025-Q20/3 |
LoseNDRA / S&P -14.39% / 10.94% |
LoseNDRA / S&P NDRA unavailable / 4.83% |
LoseNDRA / S&P NDRA unavailable / 10.63% |
| 2025-Q10/3 |
LoseNDRA / S&P -34.50% / -4.27% |
LoseNDRA / S&P NDRA unavailable / 4.98% |
LoseNDRA / S&P NDRA unavailable / 10.57% |
| 2024-Q40/3 |
LoseNDRA / S&P -11.02% / 2.41% |
LoseNDRA / S&P NDRA unavailable / 5.25% |
LoseNDRA / S&P NDRA unavailable / 6.15% |
| 2024-Q30/3 |
LoseNDRA / S&P -95.86% / 5.89% |
LoseNDRA / S&P NDRA unavailable / 5.89% |
LoseNDRA / S&P NDRA unavailable / 6.11% |
| 2024-Q20/3 |
LoseNDRA / S&P -83.28% / 4.28% |
LoseNDRA / S&P NDRA unavailable / 5.38% |
LoseNDRA / S&P NDRA unavailable / 5.12% |
| 2024-Q10/3 |
LoseNDRA / S&P -72.64% / 10.56% |
LoseNDRA / S&P NDRA unavailable / 5.71% |
LoseNDRA / S&P NDRA unavailable / 5.59% |
| 2023-Q41/3 |
WinNDRA / S&P 90.99% / 11.69% |
LoseNDRA / S&P NDRA unavailable / 6.81% |
LoseNDRA / S&P NDRA unavailable / 7.78% |
| 2023-Q30/3 |
LoseNDRA / S&P -20.71% / -3.27% |
LoseNDRA / S&P NDRA unavailable / 7.52% |
LoseNDRA / S&P NDRA unavailable / -5.03% |
| 2023-Q20/3 |
LoseNDRA / S&P -38.86% / 8.74% |
LoseNDRA / S&P NDRA unavailable / 9.50% |
LoseNDRA / S&P NDRA unavailable / -8.57% |
| 2023-Q10/3 |
LoseNDRA / S&P -43.73% / 7.50% |
LoseNDRA / S&P NDRA unavailable / 10.77% |
LoseNDRA / S&P NDRA unavailable / -15.69% |
| 2022-Q40/3 |
LoseNDRA / S&P -33.50% / 7.56% |
LoseNDRA / S&P NDRA unavailable / 11.88% |
LoseNDRA / S&P NDRA unavailable / -17.99% |
| 2022-Q31/3 |
WinNDRA / S&P 31.33% / -4.88% |
LoseNDRA / S&P NDRA unavailable / 13.47% |
LoseNDRA / S&P NDRA unavailable / -1.41% |
| 2022-Q20/3 |
LoseNDRA / S&P -40.26% / -16.10% |
LoseNDRA / S&P NDRA unavailable / 13.71% |
LoseNDRA / S&P NDRA unavailable / 11.04% |
| 2022-Q10/3 |
LoseNDRA / S&P -43.64% / -4.60% |
LoseNDRA / S&P NDRA unavailable / 15.97% |
LoseNDRA / S&P NDRA unavailable / 42.23% |
| 2021-Q40/3 |
LoseNDRA / S&P -60.00% / 11.03% |
LoseNDRA / S&P NDRA unavailable / 15.00% |
LoseNDRA / S&P NDRA unavailable / 96.40% |
| 2021-Q30/3 |
LoseNDRA / S&P -20.64% / 0.58% |
LoseNDRA / S&P NDRA unavailable / 10.77% |
LoseNDRA / S&P NDRA unavailable / 69.42% |
| 2021-Q20/3 |
LoseNDRA / S&P -16.15% / 8.55% |
LoseNDRA / S&P NDRA unavailable / 6.58% |
LoseNDRA / S&P NDRA unavailable / 51.81% |
| 2021-Q11/3 |
WinNDRA / S&P 246.67% / 6.17% |
LoseNDRA / S&P NDRA unavailable / -1.06% |
LoseNDRA / S&P NDRA unavailable / 7.39% |
| 2020-Q40/3 |
LoseNDRA / S&P 2.46% / 12.15% |
LoseNDRA / S&P NDRA unavailable / -3.72% |
LoseNDRA / S&P NDRA unavailable / -33.42% |
| 2020-Q30/3 |
LoseNDRA / S&P -23.91% / 8.93% |
LoseNDRA / S&P NDRA unavailable / -2.04% |
LoseNDRA / S&P NDRA unavailable / -27.10% |
| 2020-Q21/3 |
WinNDRA / S&P 33.24% / 20.54% |
LoseNDRA / S&P NDRA unavailable / -0.46% |
LoseNDRA / S&P NDRA unavailable / -27.11% |
| 2020-Q10/3 |
LoseNDRA / S&P -57.02% / -19.60% |
LoseNDRA / S&P NDRA unavailable / 3.47% |
LoseNDRA / S&P NDRA unavailable / -14.75% |
| 2019-Q41/3 |
WinNDRA / S&P 58.49% / 9.07% |
LoseNDRA / S&P -100.00% / 5.36% |
LoseNDRA / S&P NDRA unavailable / 2.99% |
| 2019-Q30/3 |
LoseNDRA / S&P -38.01% / 1.70% |
LoseNDRA / S&P -100.00% / 5.02% |
LoseNDRA / S&P NDRA unavailable / 0.21% |
| 2019-Q20/3 |
LoseNDRA / S&P 3.01% / 4.30% |
LoseNDRA / S&P -100.00% / 6.64% |
LoseNDRA / S&P NDRA unavailable / 8.65% |
| 2019-Q10/3 |
LoseNDRA / S&P 10.67% / 13.65% |
LoseNDRA / S&P -100.00% / 8.12% |
LoseNDRA / S&P NDRA unavailable / 14.29% |
| 2018-Q40/3 |
LoseNDRA / S&P -50.98% / -13.52% |
LoseNDRA / S&P -98.24% / 9.05% |
LoseNDRA / S&P NDRA unavailable / 18.23% |
| 2018-Q31/3 |
WinNDRA / S&P 20.00% / 7.71% |
LoseNDRA / S&P -98.49% / 10.21% |
LoseNDRA / S&P NDRA unavailable / 19.06% |
| 2018-Q20/3 |
LoseNDRA / S&P -1.92% / 3.43% |
LoseNDRA / S&P -47.67% / 9.03% |
LoseNDRA / S&P NDRA unavailable / 14.46% |
| 2018-Q10/3 |
LoseNDRA / S&P -46.50% / -0.76% |
LoseNDRA / S&P NDRA unavailable / 7.68% |
LoseNDRA / S&P NDRA unavailable / 12.46% |
| 2017-Q41/3 |
WinNDRA / S&P 52.83% / 6.64% |
LoseNDRA / S&P NDRA unavailable / 7.03% |
LoseNDRA / S&P NDRA unavailable / 13.82% |
| 2017-Q30/3 |
LoseNDRA / S&P -18.46% / 4.48% |
LoseNDRA / S&P NDRA unavailable / 5.68% |
LoseNDRA / S&P NDRA unavailable / 17.57% |
| 2017-Q20/3 |
LoseNDRA / S&P NDRA unavailable / 3.09% |
LoseNDRA / S&P NDRA unavailable / 4.83% |
LoseNDRA / S&P NDRA unavailable / 17.74% |
| 2017-Q10/3 |
LoseNDRA / S&P NDRA unavailable / 6.07% |
LoseNDRA / S&P NDRA unavailable / 3.67% |
LoseNDRA / S&P NDRA unavailable / 13.32% |
| 2016-Q40/3 |
LoseNDRA / S&P NDRA unavailable / 3.82% |
LoseNDRA / S&P NDRA unavailable / 2.09% |
LoseNDRA / S&P NDRA unavailable / 7.05% |
| 2016-Q30/3 |
LoseNDRA / S&P NDRA unavailable / 3.85% |
LoseNDRA / S&P NDRA unavailable / 0.20% |
LoseNDRA / S&P NDRA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | NDRA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 32.22% | 20.78% |
| Annualized return | 32.22% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | NDRA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.99% | 83.14% |
| Annualized return | -84.87% | 12.86% |
10Y · 2017-06-30 to 2026-08-27
| Metric | NDRA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -63.71% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |